The team of Anne-Marie Mes-Masson, researcher at the Montreal Cancer Institute, is one of the winning teams of the LeadAction competition | Breast Cancer du Sein.
Their research project entitled “Development of small molecule inhibitors of GTPase Ran as anticancer agents” is based on the discoveries made with Dr. Diane Provencher in cancer of the ovary. The funded study extends this discovery to breast cancer and therefore allows for a new collaboration with Dr. Saima Hassan, one of our young researchers at the Institute. A great story of collaboration and continuity! Congratulations to the entire Anne-Marie Mes-Masson team for this great accomplishment!
Two of the world’s most cited researchers
24 November 2021
According to the Web of Science ranking published by Clarivate Analytics, two research members from the Institut du cancer de […]
Meriem Messaoudene receives $200,000 from the Seerave Foundation
5 October 2022
Meriem Messaoudene was chosen by the Seerave Foundation, a philanthropic organization, and will receive $200,000 to continue her work on castalagin […]